These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29886583)

  • 1. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
    Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinicopathological features of primary mucosal CD30-positive T-cell lymphoproliferative disorders].
    Dong N; Zhang LN; Zheng YY; Zhang YL; Zhou XG; Xie JL
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):667-671. PubMed ID: 38955696
    [No Abstract]   [Full Text] [Related]  

  • 3. The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck.
    Wang W; Cai Y; Sheng W; Lu H; Li X
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jan; 117(1):96-104. PubMed ID: 24332333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoral CD30+ T-Cell Lymphoproliferative Disorder with Lymphomatoid Papulosis Type C Features Mimics Lymphoma Histopathologically and Immunohistochemically.
    Barbeiro CO; Silveira HA; Barbeiro RH; Martins KH; Bufalino A; Chahud F; León JE
    Head Neck Pathol; 2024 Jun; 18(1):60. PubMed ID: 38941041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck rarely involving epiglottis: clinicopathological, immunohistomchemical and genetic features of a case.
    Zhou J; Wang G; Zhang D; Yin Y; Pang X; Zhang J; Zhang Y; Li W
    Int J Clin Exp Pathol; 2015; 8(9):11685-90. PubMed ID: 26617911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal CD30-positive T-cell lymphoproliferations of the head and neck show a clinicopathologic spectrum similar to cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Sciallis AP; Law ME; Inwards DJ; McClure RF; Macon WR; Kurtin PJ; Dogan A; Feldman AL
    Mod Pathol; 2012 Jul; 25(7):983-92. PubMed ID: 22388754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
    Schwartz Z; Bowe RB; Coleman M; Magro CM
    Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological characteristics of natural killer cell enteropathy: report of two cases and review of literature].
    Huo YJ; Zhang DD; Zhou L; Li CF; Wang GN; Zhao WG; Zhang YP; Jian XY; Huang HF; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb; 51(2):108-113. PubMed ID: 35152628
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinicopathologic features of systemic EBV-positive T-cell lymphoproliferative disease of childhood].
    Jin Y; Zhou XG; He LJ; Xie JL; Zheng YY; Zhang YN; Zhang SH
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):600-8. PubMed ID: 20079188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
    Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
    Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and pathological analysis of three cases of childhood systemic EB virus positive T-cell lymphoproliferative disease].
    Wang W; Ti HJ; Nong L; Zhang S; Zhang Y; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):594-8. PubMed ID: 22898854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
    Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
    Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
    J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-regressing oral CD30-positive, EBV-negative, T-cell lymphoproliferative lesions. A poorly understood process highlighted by ominous clinicopathologic features and indolent behavior.
    Argyris PP; Ho D; Islam MN; Khurram SA; Courville EL; Morgan S; Sundick B; Soliman M; Janakiram M; Gopalakrishnan R; Koutlas IG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):698-707. PubMed ID: 34526251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30+ T-cell lymphoproliferative disorders.
    Martin JM; Wu H; Barta SK
    Chin Clin Oncol; 2019 Feb; 8(1):4. PubMed ID: 30525751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
    Kempf W; Kerl K; Mitteldorf C
    Semin Cutan Med Surg; 2018 Mar; 37(1):24-29. PubMed ID: 29719017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.